11 – 20 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
(
- Contribution to journal › Article
- 2016
-
Mark
Characterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy Women
(
- Contribution to journal › Article
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses
(
- Contribution to journal › Article
- 2015
-
Mark
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) : final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
(
- Contribution to journal › Article
-
Mark
Improving response inhibition in Parkinson's disease with atomoxetine
(
- Contribution to journal › Article
- 2014
-
Mark
Enzalutamide in metastatic prostate cancer before chemotherapy
(
- Contribution to journal › Article
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
- 2013
-
Mark
Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment : results from the SILVHIA study
(
- Contribution to journal › Article